⌘K
t
On 9 April 2026, Hikma Pharmaceuticals PLC's Persons Discharging Managerial Responsibility (PDMRs) Julie Hill and Sam Park acquired ordinary shares from the vesting of conditional awards under the 2023 Long-Term Incentive Plan. Julie Hill acquired 8,188 shares and Sam Park acquired 19,045 shares, both at nil price. On the same date, Julie Hill sold 3,121 shares for £40,851.53 and Sam Park sold 7,259 shares for £95,014.82, both at a price of £13.09 per share, to cover tax following the vesting.
| Date | 13 Apr 2026 |
| Time | 15:29:36 |
| Category | Director/PDMR dealings |
| ID | 2565A |
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 13 April 2026: Hikma Pharmaceuticals PLC (LSE: HIK) (Nasdaq Dubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMRs") have received shares as a result of the vesting of their conditional share awards which were granted on 9 April 2024 under the 2023 Long-Term Incentive Plan ("LTIP").
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Julie Hill
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||
|
a) |
Name |
Julie Hill |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status |
PDMR |
|
|
b) |
Initial notification /Amendment |
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Hikma Pharmaceuticals PLC |
|
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083 |
|
|
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards under the LTIP. |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
Nil |
8,188 |
||
|
d) |
Aggregated information |
Price(s): nil Volume(s): 8,188 |
|
|
e) |
Date of the transaction |
9 April 2026 |
|
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083 |
|
|
b) |
Nature of the transaction |
Shares sold to cover tax following the vesting of conditional awards under the LTIP. |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
£13.09 |
3,121 |
||
|
d) |
Aggregated information |
Price(s): £13.09 Volume(s): 3,121 Total(s): £40,851.53 |
|
|
e) |
Date of the transaction |
9 April 2026 |
|
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
Sam Park
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||
|
a) |
Name |
Sam Park |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status |
PDMR |
|
|
b) |
Initial notification /Amendment |
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Hikma Pharmaceuticals PLC |
|
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083 |
|
|
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards under the LTIP. |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
Nil |
19,045 |
||
|
d) |
Aggregated information |
Price(s): nil Volume(s): 19,045 |
|
|
e) |
Date of the transaction |
9 April 2026 |
|
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083 |
|
|
b) |
Nature of the transaction |
Shares sold to cover tax following the vesting of conditional awards under the LTIP. |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
£13.09 |
7,259 |
||
|
d) |
Aggregated information |
Price(s): £13.09 Volume(s): 7,259 Total(s): £95,014.82 |
|
|
e) |
Date of the transaction |
9 April 2026 |
|
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
Helen Middlemist
Group Company Secretary
+44 (0)20 7399 2760